Related references
Note: Only part of the references are listed.Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Jack Major et al.
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus
Majid Zeidi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Richard Furie et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Type I Interferons in Autoimmune Disease
Mary K. Crow et al.
Annual Review of Pathology-Mechanisms of Disease (2018)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases
Dana Saadeh et al.
EXPERIMENTAL DERMATOLOGY (2016)
A critical review of clinical trials in systemic lupus erythematosus
M. A. Mahieu et al.
LUPUS (2016)
Plasmacytoid dendritic cells orchestrate TLR7-mediated innate and adaptive immunity for the initiation of autoimmune inflammation
Hideaki Takagi et al.
SCIENTIFIC REPORTS (2016)
Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms
Alex Pellerin et al.
EMBO MOLECULAR MEDICINE (2015)
The multifaceted biology of plasmacytoid dendritic cells
Melissa Swiecki et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Sarah L. Rowland et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
Vanja Sisirak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Type I interferon signature in the initiation of the immune response in vitiligo
Antoine Bertolotti et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Pathogenic potential of interferon αβ in acute influenza infection
Sophia Davidson et al.
NATURE COMMUNICATIONS (2014)
Fueling autoimmunity: type I interferon in autoimmune diseases
Jeremy Di Domizio et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2013)
Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells
Ioannis Ioannidis et al.
JOURNAL OF VIROLOGY (2013)
Plasmacytoid dendritic cells control T-cell response to chronic viral infection
Luisa Cervantes-Barragan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus
Rachel Klein et al.
ARCHIVES OF DERMATOLOGY (2011)
Plasmacytoid Dendritic Cell Ablation Impacts Early Interferon Responses and Antiviral NK and CD8+ T Cell Accrual
Melissa Swiecki et al.
IMMUNITY (2010)
Type 1 interferons and myositis
Steven A. Greenberg
ARTHRITIS RESEARCH & THERAPY (2010)
Overview of the biology of type I interferons
George D. Kalliolias et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Neutralization of Interferon-alpha/beta-Inducible Genes and Downstream Effect in a Phase I Trial of an Anti-Interferon-alpha Monoclonal Antibody in Systemic Lupus Erythematosus
Yihong Yao et al.
ARTHRITIS AND RHEUMATISM (2009)
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage
William Vermi et al.
IMMUNOBIOLOGY (2009)
Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens
C. Lloyd et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2009)
Structural characterization of a human Fc fragment engineered for lack of effector functions
Vaheh Oganesyan et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2008)
Pyogenic bacterial infections in humans with MyD88 deficiency
Horst von Bernuth et al.
SCIENCE (2008)
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Michel Gilliet et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Selective predisposition to bacterial infections in IRAK-4-deficient children:: IRAK-4-dependent TLRs are otherwise redundant in protective immunity
Cheng-Lung Ku et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Plasmacytoid dendritic cell-specific receptor ILT7-FcεRIγ inhibits Toll-like receptor-induced interferon production
Wei Cao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Jacques Banchereau et al.
IMMUNITY (2006)
Human TLR-7-,-8-, and -9-mediated induction of IFN-α/β and -λ is IRAK-4 dependent and redundant for protective immunity to viruses
K Yang et al.
IMMUNITY (2005)
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
J Albrecht et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2004)
Induction of interferon-a production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late anoptotic cells and lupus IgG
T Lövgren et al.
ARTHRITIS AND RHEUMATISM (2004)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
Analysis of gene, expression profiles in human systemic lupus erythematosus using oligonucleotide microarray
GM Han et al.
GENES AND IMMUNITY (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
L Farkas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus
S Blomberg et al.
LUPUS (2001)
BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood
A Dzionek et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
